GordonMD Global Investments LP: summary

GordonMD Global Investments LP reported 16 positions with a reported value of $206.66M in its 13F for Q2 2026. Compared with Q1 2026: 1 new positions, 1 exited.

Top positions

• Kyverna Therapeutics, Inc.
• PYXIS ONCOLOGY INC
• Taysha Gene Therapies Inc
• TEVA PHARMACEUTICAL INDS LTD
• Vir Biotechnology Inc
• Allogene Therapeutics Inc
• Celldex Therapeutics Inc
• Editas Medicine Inc
• Ultragenyx Pharmaceutical Inc
• Bausch + Lomb Corp